Lunai Bioworks Inc.
LNAI
$0.56
$0.34162.77%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 12.40M | 14.99M | 17.88M | 18.88M | 22.31M |
| Depreciation & Amortization | 117.40K | 138.20K | 129.10K | 127.60K | 125.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.58M | 15.30M | 18.55M | 19.90M | 24.50M |
| Operating Income | -12.58M | -15.30M | -18.55M | -19.90M | -24.50M |
| Income Before Tax | -125.52M | -130.98M | -178.01M | -67.01M | -126.19M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -125.52 | -130.98 | -178.01 | -67.01 | -126.19 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -125.52M | -130.98M | -178.01M | -67.01M | -126.19M |
| EBIT | -12.58M | -15.30M | -18.55M | -19.90M | -24.50M |
| EBITDA | -12.46M | -15.16M | -18.42M | -19.77M | -24.38M |
| EPS Basic | -7.14 | -7.51 | -10.40 | -4.24 | -9.65 |
| Normalized Basic EPS | -0.44 | -0.57 | -0.73 | -0.87 | -1.22 |
| EPS Diluted | -7.14 | -7.51 | -10.40 | -4.25 | -9.66 |
| Normalized Diluted EPS | -0.44 | -0.57 | -0.73 | -0.87 | -1.22 |
| Average Basic Shares Outstanding | 79.85M | 72.55M | 66.03M | 63.49M | 58.19M |
| Average Diluted Shares Outstanding | 80.01M | 72.71M | 66.19M | 63.65M | 58.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |